Journals / Toraks Dergisi / 2003 / Cilt: 4 - Sayı: 1

Clinical, radiological laboratory parameters and diagnostic procedures in sarcoidosis

Sarkoidozda klinik, radyolojik, laboratuvarla ilgili parametreler ve tanı yöntemleri

Pages
48–52
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

We did not find any relationship between the radiological stage of disease and symptoms, tuberculin skin test results, sACE levels, FEV1 and FVC values or lymphocyte percentages in BAL fluid.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The aim of this study was to evaluate the results of clinical, laboratory and radiological parameters, and the relationship of these parameters with radiological stage in 73 patients diagnosed as sarcoidosis between 1995 and 2001.
📊
Key Findings & Data:Fifty three of the patients were female, 20 were male and the mean age was 45.5±13 (14-85) years.
💡
Conclusion & Impact:We did not find any relationship between the radiological stage of disease and symptoms, tuberculin skin test results, sACE levels, FEV1 and FVC values or lymphocyte percentages in BAL fluid.
🔬Design:Research Article
📍Scope:2001 Verileri
⚙️Variables:Tanı teknik ve işlemleri · Sarkoidoz · Diagnostic Techniques and Procedures

Abstract

The aim of this study was to evaluate the results of clinical, laboratory and radiological parameters, and the relationship of these parameters with radiological stage in 73 patients diagnosed as sarcoidosis between 1995 and 2001. Fifty three of the patients were female, 20 were male and the mean age was 45.5±13 (14-85) years. The most common symptoms were cough (65.7%), dyspnea (38.3%), and weight loss (24.6%). Erythema nodosum, peripheral lymphadenopathy, hepatomegaly, splenomegaly, ophthalmic lesions, skin involvement, bilateral parotid gland enlargement, bone involvement, and buccal mucosa involvement were reported as 26, 4.1, 4.1, 2.7, 2.7, 2.7, 1.4, 1.4, 1.4%, respectively. Tuberculin skin test (PPD) was negative in 46 of the 67 patients (68.6%). Serum calcium levels were elevated in 9 of the 50 cases (18%), serum angiotensin converting enzyme (sACE) levels were elevated in 9 of the 16 patients (56.2%). The CD4/CD8 ratio in bronchoalveolar lavage (BAL) fluid was higher than 3.5 in 14 of the 20 patients (70%). Scalene lymph node biopsy (59%) and transbronchial lung biopsy (16.4%) revealed the histopathological diagnosis in most of the patients. According to the radiological staging, 21 cases (28.7%) were evaluated as stage 1, 42 cases (57.5%) as stage 2, 10 cases (13.8%) as stage 3. We did not find any relationship between the radiological stage of disease and symptoms, tuberculin skin test results, sACE levels, FEV1 and FVC values or lymphocyte percentages in BAL fluid.

Özet

Çalışmamızda 1995-2001 yıllarında sarkoidoz tanısı konulan 73 olgunun klinik, laboratuvar, radyolojik parametrelerinin geriye dönük olarak değerlendirilmesi ve radyolojik evre ile bu parametreler arasındaki ilişkinin incelenmesi amaçlanmıştır. Olguların 53'ü kadın, 20'si erkek ve yaş ortalaması 45.5±13 (14-85) yıldı. En sık rastlanan semptomlar öksürük (%65.7), dispne (%38.3) ve kilo kaybı (%24.6) idi. 19 olguda (%26) eritema nodosum, üçer olguda (%4.1) periferik lenfadenopati ve hepatomegali, ikişer olguda (%2.7) splenomegali, göz ve deri tutulumu, birer olguda (%1.4) bilateral parotis bezi büyümesi, kemik ve ağız mukozası tutulumu mevcuttu. Tüberkülin deri testi (PPD) yapılan 67 olgunun 46'sında (%68.6) negatiflik saptandı. Serum kalsiyum düzeyi ölçülen 50 olgunun 9'unda (%18), serum anjiyotensin dönüştürücü enzim (ACE) düzeyi ölçülen 16 olgunun 9'unda (%56.2) yüksek düzeyler saptandı. Bronkoalveoler lavajda (BAL) CD4/CD8 oranı, 20 olgunun 14'ünde (%70) 3.5'in üzerindeydi. Histopatolojik olarak sarkoidoz tanısı en sık skalen lenf bezi biyopsisi (%59) ve transbronşiyal akciğer biyopsisiyle (%16.4) konuldu. Radyolojik evrelemeye göre 21 olgu (%28.7) Evre 1, 42 olgu (%57.5) Evre 2, 10 olgu (%13.8) Evre 3 olarak değerlendirildi. Radyolojik evre ile semptomlar, tüberkülin testi yanıtı, serum ACE düzeyi, FEV1, FVC değerleri ve BAL sıvısındaki lenfosit yüzdeleri arasında ilişki saptanmadı.

🔖

Cite This Article

YALNIZ, E., KÖMÜRCÜOĞLU, A., POLAT, G. E., UTKANER, G., YÜKSEL, M. (2003). Clinical, radiological laboratory parameters and diagnostic procedures in sarcoidosis. Toraks Dergisi, Cilt: 4 - Sayı: 1, 48–52. https://ajindex.com/articles/368121

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Moller DR. Sistemic Sarcoidosis. In:Fishman AP (ed). Fishman’s Pulmonary Diseases and Disorders, Mc Graw-Hill, New York 1998;55-1068
  2. Neuman LS, Rose C. Sarcoidosis. The New England Journal of Medicine 1997;336:1124-33
  3. Anonymous. Statement on Sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee. February 1999. Am J Respir Crit Care Med 1999;160:736-55
  4. Iwai K, Sekiguchi M, Hosoda Y et al. Racial difference in cardiac sarcoidosis incidence observed at autopsy. Sarcoidosis 1994;11:26-31
  5. Milman N and Selroos O. Pulmonary sarcoidosis in the Nordic Countries 1950-1982: epidemiology and clinical picture. Sarcoidosis 7:50-7
  6. Tuncer LY, Sevim T, Mihmanlı ve ark. 48 sarkoidoz olgusunun değerlendirilmesi. XXI. Ulusal Türk Tüberküloz ve Göğüs Hastalıkları Kongresi Özet kitabı, 1996;SB20
  7. Çelikoğlu S. Clinical features of sarcoidosis in 379 patients living in Turkey: The results of 30 years experience. Congress of Macedonian Respiratory Society, Invited lecture, 1997
  8. Erdem F, Karacan Ö, Özdemir Ö ve ark. 1988-1995 yılları arasında izlenen sarkoidozlu olgularda radyolojik bulgular ve tanı yöntemleri. Tüberküloz ve Toraks 1997;45:158-61
  9. Sipahi S, Çağatay H. Clinical Features of Sarcoidosis in 379 Patient from Turkey. ERS 1998:102
  10. Tabak L, Kılıçarslan Z, Kıyan E ve ark. 147 Sarkoidoz hastasının klinik özellikleri. Solunum 2001;3:80-5
  11. Çetinkaya E, Yıldız P, Kadakal F ve ark. Sarkoidozda klinik, laboratuvar, fonksiyonel parametreler ve prognoz. Solunum Hastalıkları 2001;12:284-8
  12. Karabıyıkoğlu G, Enacar N. Sarkoidozisli hastalarımızda klinikradyolojik ve pulmoner fonksiyonlardaki değişmeler. Tüberküloz ve Toraks 1987;35:1-8
  13. Studdy PR, James DG. The specificity and sensitivity of serum angiotensin-converting enzyme in sarcoidosis and other diseases. Experiences in 12 centers in six diferent countries. In: Chretien J, Marsac J, Saltiel JC, eds. Sarcoidosis. Paris: Pergamon Press, 1983;332-44
  14. De Remee RA, Rohrbach MS. Serum angiotensin-converting enzyme activity in evaluating the clinical course of sarcoidosis. Ann Intern Med 1980;92:361-65
  15. Verstraeten A, Demedts M et al. Predictive value of bronchoalveolar lavage in pulmonary sarcoidosis. Chest 1990;98:560-67
  16. Ward K, O’connor C, Odlum C et al. Prognostic value